(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GLYCOM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GLYCOM

ST13

US500000079129179

Class

1, 5

Filing

79129179

Registration

4442030

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

03/31/2026

Trademark type

Word

Nice classes

1, 5

Filing date

09/26/2012

Registration date

12/03/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/06/2026

Last transaction

03/31/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Hørsholm, DK

Examiner

DE JONGE, KATHLEEN

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

GLYCOM A/S

Representatives

Stephanie L. Crigler Dinsmore & Shohl LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Human milk oligosaccharide (HMO) preparations for use in industry and as raw material in the manufacture of other goods and other than for medical use; human milk oligosaccharide (HMO) additives for use in the manufacture of pharmaceuticalsnutraceuticalsinfant formulafoodstuffs and animal foods; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for the food industry; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for scientific use other than for medical or veterinary use; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for industrial use; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for use in the manufacture of pharmaceuticalsnutraceuticalsinfant formulafoodstuffs and animal foods; chemicals for use as a supplement in the preparation of dietary supplements and infant formula

Class 5

Dietetic food and substanceshuman milk oligosaccharide adapted for medical or veterinary usefood for babies and infant formula; dietary supplements for humans and animals; medicated food additives in the nature of dietary supplements containing human milk oligosaccharide for humans and for animals; medicated preparations for use as additives for food for human or animal consumptionhuman milk oligosaccharide for medical or veterinary purposesvitamin preparations for use as a supplement for dietary supplements and infant formula; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humansincluding for infantsfor animals; mineral food supplements; colostrum supplements; dietary supplemental drinks and nutritionally fortified beverages; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds for medical purposes; human milk oligosaccharide additives being dietary and nutritional supplements for use as supplements in connection with pharmaceuticalsnutraceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for medical use

Publications

History of USPTO decisions and trademark events.

50 publications found

C71T

CANCELLED SECTION 71

03/06/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/15/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/03/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/14/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/05/2020

71AG

REGISTERED-SEC.71 ACCEPTED

02/05/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/23/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/16/2020

ES71

TEAS SECTION 71 RECEIVED

12/02/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/03/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/08/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/08/2018

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/24/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/15/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/15/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/21/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/03/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/17/2014

FIMP

FINAL DISPOSITION PROCESSED

03/17/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/03/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/17/2013

PUBO

PUBLISHED FOR OPPOSITION

09/17/2013

GPNX

NOTIFICATION PROCESSED BY IB

09/16/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/28/2013

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/28/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/28/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/10/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/07/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/06/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/05/2013

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/05/2013

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/19/2013

GNFR

FINAL REFUSAL E-MAILED

07/19/2013

CNFR

FINAL REFUSAL WRITTEN

07/19/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/19/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/19/2013

ALIE

ASSIGNED TO LIE

07/11/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/09/2013

RFNT

REFUSAL PROCESSED BY IB

06/03/2013

MAFR

APPLICATION FILING RECEIPT MAILED

05/18/2013

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/15/2013

RFRR

REFUSAL PROCESSED BY MPU

05/15/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/15/2013

CNRT

NON-FINAL ACTION WRITTEN

05/14/2013

DOCK

ASSIGNED TO EXAMINER

05/14/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/14/2013

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/13/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/09/2013

Continuous trademark protection

Get notified about every new filing that threatens GLYCOM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.